These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 36685592)

  • 1. Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2
    Takacs GP; Kreiger CJ; Luo D; Tian G; Garcia JS; Deleyrolle LP; Mitchell DA; Harrison JK
    Front Immunol; 2022; 13():993444. PubMed ID: 36685592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF1R Ligands Expressed by Murine Gliomas Promote M-MDSCs to Suppress CD8
    Takacs GP; Garcia JS; Hodges CA; Kreiger CJ; Sherman A; Harrison JK
    Cancers (Basel); 2024 Sep; 16(17):. PubMed ID: 39272914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioma-derived M-CSF and IL-34 license M-MDSCs to suppress CD8
    Takacs GP; Garcia JS; Hodges CA; Kreiger CJ; Sherman A; Harrison JK
    bioRxiv; 2024 Jun; ():. PubMed ID: 38895268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.
    Flores-Toro JA; Luo D; Gopinath A; Sarkisian MR; Campbell JJ; Charo IF; Singh R; Schall TJ; Datta M; Jain RK; Mitchell DA; Harrison JK
    Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1129-1138. PubMed ID: 31879345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gas6 Promotes Inflammatory (CCR2
    Laurance S; Bertin FR; Ebrahimian T; Kassim Y; Rys RN; Lehoux S; Lemarié CA; Blostein MD
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1315-1322. PubMed ID: 28450294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells.
    Chang AL; Miska J; Wainwright DA; Dey M; Rivetta CV; Yu D; Kanojia D; Pituch KC; Qiao J; Pytel P; Han Y; Wu M; Zhang L; Horbinski CM; Ahmed AU; Lesniak MS
    Cancer Res; 2016 Oct; 76(19):5671-5682. PubMed ID: 27530322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.
    Amsellem V; Abid S; Poupel L; Parpaleix A; Rodero M; Gary-Bobo G; Latiri M; Dubois-Rande JL; Lipskaia L; Combadiere C; Adnot S
    Am J Respir Cell Mol Biol; 2017 May; 56(5):597-608. PubMed ID: 28125278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CCL2/CCL7/CCL12/CCR2 pathway is substantially and persistently upregulated in mice after traumatic brain injury, and CCL2 modulates the complement system in microglia.
    Popiolek-Barczyk K; Ciechanowska A; Ciapała K; Pawlik K; Oggioni M; Mercurio D; De Simoni MG; Mika J
    Mol Cell Probes; 2020 Dec; 54():101671. PubMed ID: 33160071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes.
    Parillaud VR; Lornet G; Monnet Y; Privat AL; Haddad AT; Brochard V; Bekaert A; de Chanville CB; Hirsch EC; Combadière C; Hunot S; Lobsiger CS
    J Neuroinflammation; 2017 Mar; 14(1):60. PubMed ID: 28320442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resident stroma-secreted chemokine CCL2 governs myeloid-derived suppressor cells in the tumor microenvironment.
    Oo MW; Kawai H; Takabatake K; Tomida S; Eguchi T; Ono K; Shan Q; Ohara T; Yoshida S; Omori H; Sukegawa S; Nakano K; Okamoto K; Sasaki A; Nagatsuka H
    JCI Insight; 2022 Jan; 7(1):. PubMed ID: 34874922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR2 and CCR5 co-inhibition modulates immunosuppressive myeloid milieu in glioma and synergizes with anti-PD-1 therapy.
    Pant A; Hwa-Lin Bergsneider B; Srivastava S; Kim T; Jain A; Bom S; Shah P; Kannapadi N; Patel K; Choi J; Cho KB; Verma R; Yu-Ju Wu C; Brem H; Tyler B; Pardoll DM; Jackson C; Lim M
    Oncoimmunology; 2024; 13(1):2338965. PubMed ID: 38590799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocytes expressing activin A and CCR2 exacerbate chronic testicular inflammation by promoting immune cell infiltration.
    Hasan H; Peng W; Wijayarathna R; Wahle E; Fietz D; Bhushan S; Pleuger C; Planinić A; Günther S; Loveland KL; Pilatz A; Ježek D; Schuppe HC; Meinhardt A; Hedger MP; Fijak M
    Hum Reprod; 2024 May; ():. PubMed ID: 38775335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression.
    Alban TJ; Bayik D; Otvos B; Rabljenovic A; Leng L; Jia-Shiun L; Roversi G; Lauko A; Momin AA; Mohammadi AM; Peereboom DM; Ahluwalia MS; Matsuda K; Yun K; Bucala R; Vogelbaum MA; Lathia JD
    Front Immunol; 2020; 11():1191. PubMed ID: 32625208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocytic myeloid-derived suppressor cells home to tumor-draining lymph nodes via CCR2 and locally modulate the immune response.
    Lahmar Q; Schouppe E; Morias Y; Van Overmeire E; De Baetselier P; Movahedi K; Laoui D; Sarukhan A; Van Ginderachter JA
    Cell Immunol; 2021 Apr; 362():104296. PubMed ID: 33556903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subsets of myeloid-derived suppressor cells in hepatocellular carcinoma express chemokines and chemokine receptors differentially.
    Zhao W; Xu Y; Xu J; Wu D; Zhao B; Yin Z; Wang X
    Int Immunopharmacol; 2015 Jun; 26(2):314-21. PubMed ID: 25891236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair.
    Lu H; Huang D; Ransohoff RM; Zhou L
    FASEB J; 2011 Oct; 25(10):3344-55. PubMed ID: 21697550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.
    Otvos B; Silver DJ; Mulkearns-Hubert EE; Alvarado AG; Turaga SM; Sorensen MD; Rayman P; Flavahan WA; Hale JS; Stoltz K; Sinyuk M; Wu Q; Jarrar A; Kim SH; Fox PL; Nakano I; Rich JN; Ransohoff RM; Finke J; Kristensen BW; Vogelbaum MA; Lathia JD
    Stem Cells; 2016 Aug; 34(8):2026-39. PubMed ID: 27145382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?
    Fei L; Ren X; Yu H; Zhan Y
    Front Immunol; 2021; 12():771210. PubMed ID: 34804061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The beta-chemokines CCL2 and CCL7 are two novel differentiation factors for midbrain dopaminergic precursors and neurons.
    Edman LC; Mira H; Arenas E
    Exp Cell Res; 2008 Jun; 314(10):2123-30. PubMed ID: 18420193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
    Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
    Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.